nyxoah

What is nyxoah?

nyxoah is a company within the Medical Technology category. Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Its lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, a common sleep-disordered breathing condition.

When was nyxoah founded and where is it based?

nyxoah was founded in Not specified in the provided context. and is headquartered in Not specified in the provided context..

What is nyxoah's Brand Authority Index tier?

nyxoah is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.

How accurately do AI models describe nyxoah?

AI narrative accuracy for nyxoah is Strong.

How do AI models position nyxoah competitively?

AI models classify nyxoah as a Challenger. AI names competitors first.

How visible is nyxoah in buyer-intent AI queries?

nyxoah appeared in 3 of 3 sampled buyer-intent queries (100%). The brand's core product and unique selling proposition are clearly articulated, making it discoverable for specific searches related to its technology and the condition it treats. However, for broader queries like 'sleep apnea treatment,' direct discoverability might depend on SEO efforts against more generic solutions.

What do AI models currently say about nyxoah?

Nyxoah is perceived as an innovative medical technology company dedicated to improving the lives of Obstructive Sleep Apnea (OSA) patients through advanced, patient-friendly neurostimulation solutions like the Genio® system, aiming to make sleep simple and healthy. Key gap: No key discrepancies found within the provided text, as it is a singular source describing the company.

How many facts about nyxoah are well-documented vs need fixing vs retrieval-dependent?

Of 4 key facts verified about nyxoah, 4 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.

What is nyxoah's biggest AI narrative vulnerability?

The provided text is a self-description and does not highlight any vulnerabilities. Potential vulnerabilities, if any, would relate to market adoption, regulatory approvals, or competition from established OSA treatments like CPAP machines or other neurostimulation devices.

What problems does nyxoah solve for buyers?

Buyers turn to nyxoah for Lifestyle modifications: Includes weight loss, avoiding alcohol and sedatives before bed, sleeping on one's side, and quitting smoking. These can alleviate mild OSA symptoms but are often insufficient, Untreated OSA: Ignoring Obstructive Sleep Apnea, which the brand highlights is associated with increased mortality risk, cardiovascular diseases, depression, and stroke., among 2 documented problem areas.

What questions do buyers ask AI about nyxoah?

Buyers evaluating nyxoah typically ask AI models about "Nyxoah Genio system", "hypoglossal neurostimulation OSA", "sleep apnea treatment leadless battery-free", and 3 similar queries.

What does nyxoah offer?

nyxoah's core products are Genio® system (hypoglossal neurostimulation therapy for OSA).

How is nyxoah priced?

nyxoah uses Not specified in the provided context. Typically, medical devices are sold to healthcare providers or covered by insurance..

Who does nyxoah target?

nyxoah serves Patients globally (ages 30-69) suffering from moderate to severe Obstructive Sleep Apnea (OSA)..

What differentiates nyxoah from competitors?

nyxoah The Genio® system is described as a 'patient-centered, leadless and battery-free hypoglossal neurostimulation therapy,' differentiating it from other stimulation devices that may require leads or external batteries.

Verified public facts

Founded: Not specified in the provided context. (source: official website)

Headquarters: Not specified in the provided context. (source: official website)

Problems this brand solves

• Lifestyle modifications: Includes weight loss, avoiding alcohol and sedatives before bed, sleeping on one's side, and quitting smoking. These can alleviate mild OSA symptoms but are often insufficient
• Untreated OSA: Ignoring Obstructive Sleep Apnea, which the brand highlights is associated with increased mortality risk, cardiovascular diseases, depression, and stroke.

Buyers search for

• Nyxoah Genio system
• hypoglossal neurostimulation OSA
• sleep apnea treatment leadless battery-free
• CPAP machines: Continuous Positive Airway Pressure (CPAP) therapy uses a machine to deliver a continuous stream of air through a mask, keeping the airway open during sleep. It is a widely adopted and
• Oral appliances: Custom-fitted dental devices worn during sleep to reposition the jaw or tongue, preventing airway collapse. Suitable for mild to moderate OSA.
• Surgical interventions: Various surgical procedures exist to remove or stiffen excess tissue in the throat, or to reposition the jaw, to open the airway. Examples include uvulopalatopharyngoplasty (UP

About this profile

This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.

If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile